136 related articles for article (PubMed ID: 27177836)
1. Higher Plasma Concentrations of Platelet Microparticles in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Sun C; Zhao WB; Chen Y; Hu HY
Can J Cardiol; 2016 Nov; 32(11):1325.e1-1325.e10. PubMed ID: 27177836
[TBL] [Abstract][Full Text] [Related]
2. Differences in microparticle release in patients with acute coronary syndrome and stable angina.
Biasucci LM; Porto I; Di Vito L; De Maria GL; Leone AM; Tinelli G; Tritarelli A; Di Rocco G; Snider F; Capogrossi MC; Crea F
Circ J; 2012; 76(9):2174-82. PubMed ID: 22664782
[TBL] [Abstract][Full Text] [Related]
3.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
4. Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome.
Koganti S; Eleftheriou D; Gurung R; Hong Y; Brogan P; Rakhit RD
Thromb Res; 2021 Oct; 206():60-65. PubMed ID: 34418680
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
[TBL] [Abstract][Full Text] [Related]
7. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
8. [Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].
Lu HY; Chen D; Gu J; Song LX; Chen M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):678-83. PubMed ID: 23815921
[TBL] [Abstract][Full Text] [Related]
9. Microparticles in acute coronary syndrome.
Mavroudis CA; Eleftheriou D; Hong Y; Majumder B; Koganti S; Sapsford R; North J; Lowdell M; Klein N; Brogan P; Rakhit RD
Thromb Res; 2017 Aug; 156():109-116. PubMed ID: 28624718
[TBL] [Abstract][Full Text] [Related]
10. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke.
Dai DF; Thajeb P; Tu CF; Chiang FT; Chen CH; Yang RB; Chen JJ
J Am Coll Cardiol; 2008 Jun; 51(22):2173-80. PubMed ID: 18510966
[TBL] [Abstract][Full Text] [Related]
12. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S;
Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
14. Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes.
Liu Y; He Z; Zhang Y; Dong Z; Bi Y; Kou J; Zhou J; Shi J
Coron Artery Dis; 2016 Aug; 27(5):365-75. PubMed ID: 27058313
[TBL] [Abstract][Full Text] [Related]
15. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.
Kafian S; Mobarrez F; Wallén H; Samad B
Platelets; 2015; 26(5):467-73. PubMed ID: 25025694
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tongxinluo capsule on platelet activities and vascular endothelial functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):487-91. PubMed ID: 21608219
[TBL] [Abstract][Full Text] [Related]
17. D-dimer plasma levels in NSTE-ACS patient.
Charoensri N; Pornratanarangsi S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S39-45. PubMed ID: 21721427
[TBL] [Abstract][Full Text] [Related]
18. Platelet microparticles in immune thrombocytopenic purpura in pediatrics.
Tantawy AA; Matter RM; Hamed AA; Shams El Din El Telbany MA
Pediatr Hematol Oncol; 2010 May; 27(4):283-96. PubMed ID: 20426519
[TBL] [Abstract][Full Text] [Related]
19. Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?
Williams MS; Rogers HL; Wang NY; Ziegelstein RC
Psychosomatics; 2014; 55(3):252-60. PubMed ID: 24374086
[TBL] [Abstract][Full Text] [Related]
20. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
Montoro-García S; Shantsila E; Tapp LD; López-Cuenca A; Romero AI; Hernández-Romero D; Orenes-Piñero E; Manzano-Fernández S; Valdés M; Marín F; Lip GY
Atherosclerosis; 2013 Apr; 227(2):313-22. PubMed ID: 23415055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
